Bristol Myers Squib, Wallingford, Connecticut, United States

AstraZeneca Neuroscience – Cambridge, Massachusetts, United States

University of Washington, Department of Global Health - Seattle, Washington, United States

  • Jaisri R. Lingappa, M.D., Ph.D. (Retroviridae - HIV / Cell biology of viral capsid assembly)
  • Wes Van Voorhis, M.D., Ph.D. (Parasitology)

Centers for Disease Control and Prevention - Atlanta, Georgia, United States

  • Xianfu Wu, Ph.D. (Rhabdoviridae - RABV)

Columbia University - New York, New York, United States

  • W. Ian Lipkin, M.D. (Flavoviridae - DENV / Paramyxoviridae - NIPV / Rhabdoviridae - RABV)

Heinrich Heine University of Düsseldorf Medical School - Düsseldorf, Germany

  • Carsten Korth, MD, Ph.D.

US Army Medical Research Institute of Infection Diseases* - Fort Detrick, Maryland, United States

  • Pam Glass, Ph.D.
  • Sina Bavari, Ph.D.

Program for Appropriate Technology in Health, PATH - Seattle, Washington, United States

 

*The views, opinions, and findings  contained herein are those of the authors and should not be construed as  an official Department of the Army position, policy, or decision unless  so designated by other documentation. Research was conducted in  compliance with the Animal Welfare Act and other  federal statutes and  regulations relating to animals and experiments involving animals and  adheres to principles stated in the Guide for the Care and Use of  Laboratory Animals, National  Research Council, 1996.  The facility  where this research was conducted is fully accredited by the Association  for the Assessment and Accreditation of Laboratory Animal Care  International.